DHR

Danaher (DHR)

Danaher Corporation

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:DHR

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/09	20 : 00	PR Newswire (US)	Danaher Launches Collaboration with Johns Hopkins University Aiming to Improve Neurological Diagnosis	NYSE:DHR	Danaher Corporation
2024/05/08	05 : 45	PR Newswire (US)	Danaher to Present at Bank of America Securities Healthcare Conference	NYSE:DHR	Danaher Corporation
2024/05/08	05 : 15	PR Newswire (US)	Danaher Announces Quarterly Dividend	NYSE:DHR	Danaher Corporation
2024/05/03	22 : 06	PR Newswire (US)	Curiox Biosystems and Beckman Coulter Life Sciences Announce a Partnership Combining C-FREE™ Technology with DURA Innovations for Hands-Free Washed Sample Preparation for Flow Cytometry	NYSE:DHR	Danaher Corporation
2024/04/23	19 : 00	PR Newswire (US)	Danaher Reports First Quarter 2024 Results	NYSE:DHR	Danaher Corporation
2024/03/22	05 : 15	PR Newswire (US)	Danaher Schedules First Quarter 2024 Earnings Conference Call	NYSE:DHR	Danaher Corporation
2024/02/28	06 : 15	PR Newswire (US)	Danaher to Present at TD Cowen Health Care Conference	NYSE:DHR	Danaher Corporation
2024/02/23	06 : 15	PR Newswire (US)	Danaher Commits to Set Science-Based, Net-Zero Greenhouse Gas Emission Reduction Targets	NYSE:DHR	Danaher Corporation
2024/02/22	06 : 15	PR Newswire (US)	Danaher Announces Quarterly Dividend	NYSE:DHR	Danaher Corporation
2024/02/05	21 : 30	PR Newswire (US)	Danaher Launches Collaboration with Cincinnati Children's Hospital Medical Center Aiming to Improve Patient Safety in Early Drug Development	NYSE:DHR	Danaher Corporation
2024/01/30	20 : 00	PR Newswire (US)	Danaher Reports Fourth Quarter and Full Year 2023 Results	NYSE:DHR	Danaher Corporation
2024/01/09	21 : 30	PR Newswire (US)	Danaher, Jennifer Doudna, and Innovative Genomics Institute Launch Danaher-IGI Beacon for CRISPR Cures with Aim to Address Hundreds of Diseases Using Gene-editing Platform Solution	NYSE:DHR	Danaher Corporation
2024/01/09	06 : 57	Dow Jones News	Danaher Says 4Q Adjusted. Revenue to Fall by Less Than Forecast	NYSE:DHR	Danaher Corporation
2024/01/09	06 : 15	PR Newswire (US)	Danaher CEO to Comment on Financial Performance	NYSE:DHR	Danaher Corporation
2024/01/03	07 : 00	PR Newswire (US)	Danaher to Present at J.P. Morgan Healthcare Conference	NYSE:DHR	Danaher Corporation
2023/12/22	06 : 30	PR Newswire (US)	Danaher Schedules Fourth Quarter 2023 Earnings Conference Call	NYSE:DHR	Danaher Corporation
2023/12/14	06 : 06	GlobeNewswire Inc.	Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA Polymerase	NYSE:DHR	Danaher Corporation
2023/12/06	21 : 30	PR Newswire (US)	Danaher Completes Acquisition of Abcam	NYSE:DHR	Danaher Corporation
2023/12/06	07 : 14	Dow Jones News	Danaher Cuts Quarterly Dividend to 24 Cents	NYSE:DHR	Danaher Corporation
2023/12/06	06 : 30	PR Newswire (US)	Danaher Announces Quarterly Dividend	NYSE:DHR	Danaher Corporation
2023/11/22	06 : 15	PR Newswire (US)	Danaher to Present at Evercore ISI HealthCONx Conference	NYSE:DHR	Danaher Corporation
2023/11/22	04 : 22	Dow Jones News	Danaher on Track for Largest Percent Increase in Almost a Year -- Data Talk	NYSE:DHR	Danaher Corporation
2023/10/31	20 : 30	PR Newswire (US)	Danaher appoints Christopher Riley to Executive Vice President for Biotechnology	NYSE:DHR	Danaher Corporation
2023/10/24	19 : 41	Dow Jones News	Danaher 3Q Earnings, Sales Decline but Beat Estimates	NYSE:DHR	Danaher Corporation
2023/10/24	19 : 00	PR Newswire (US)	Danaher Reports Third Quarter 2023 Results	NYSE:DHR	Danaher Corporation
2023/10/17	19 : 34	IH Market News	Keep An Eye Out: Pre-Market Movers And Analyst Recommendations	NYSE:DHR	Danaher Corporation
2023/09/30	21 : 00	PR Newswire (US)	Danaher Corporation Completes Separation of Veralto Corporation	NYSE:DHR	Danaher Corporation
2023/09/29	07 : 17	PR Newswire (US)	Veralto Set to Join S&P 500; Vestis to Join S&P MidCap 400; Others to Join S&P SmallCap 600	NYSE:DHR	Danaher Corporation
2023/09/27	05 : 15	PR Newswire (US)	Danaher Schedules Third Quarter 2023 Earnings Conference Call	NYSE:DHR	Danaher Corporation
2023/09/19	20 : 43	PR Newswire (US)	Danaher to Provide Cepheid's Tuberculosis Test to the Global Fund at Cost	NYSE:DHR	Danaher Corporation